Radial versus femoral access for orally anticoagulated patients

Catheterization and Cardiovascular Interventions

Volumn 76, Issue 4, 2010, Pages 493-499

  Ziakas, Antonios G ^a   Koskinas, Konstantinos C ^a   Gavrilidis, Stavros ^a   Giannoglou, George D ^a   Hadjimiltiades, Stavros ^a   Gourassas, Ioannis ^a   Theofilogiannakos, Efstratios ^a   Economou, Fotios ^a   Styliadis, Ioannis ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

arterial access; coronary angiography; coronary intervention; femoral; radial; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR DISEASE; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; HEART CATHETERIZATION; HEART DISEASE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; RADIAL ARTERY; VASCULAR ACCESS;

ADMINISTRATION, ORAL; AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; BLOOD COAGULATION; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; FEMALE; FEMORAL ARTERY; GREECE; HEART CATHETERIZATION; HEART DISEASES; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PILOT PROJECTS; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RADIAL ARTERY; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; WARFARIN;

EID: 78649407258     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22527     Document Type: Article

References (30)

1. Helft G, Gilard M, Le Feuvre C, Zaman AG,. Drug insight: Antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nat Clin Pract Cardiovasc Med 2006; 3: 673-680.
2. Lip GYH, Karpha M,. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention. The need for consensus and a management guideline. Chest 2006; 130: 1823-1827.
3. Douketis JD, Johnson JA, Turpie AG,. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin. Assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164: 1319-1326.
4. Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS,. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658-1663.
5. Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A,. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: Comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116: 2531-2534.
6. Annala AP, Karjalainen PP, Porela P, Nyman K, Ylitalo A, Airaksinen JK,. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol 2008; 102: 386-390.
7. El-Jack SS, Ruygrok PN, Webster MW, Stewart JT, Bass NM, Armstrong GP, Ormiston JA, Pornratanarangsi S,. Effectiveness of manual pressure hemostasis following transfemoral coronary angiography in patients on therapeutic warfarin anticoagulation. Am J Cardiol 2006; 97: 485-488.
8. Karjalainen PP, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen MA, Puurunen M, Airaksinen TJ, Nyman K, Vahlberg T, Airaksinen KE,. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 2008; 29: 1001-1010.
9. Jessup DB, Coletti AT, Muhlestein JB, Barry WH, Shean FC, Whisenant BK,. Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy. Catheter Cardiovasc Interv 2003; 60: 180-184.
10. Choussat R, Black A, Bossi I, Fajadet J, Marco J,. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade: Comparison of transradial vs transfemoral arterial access. Eur Heart J 2000; 21: 662-667.
11. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR,. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009; 157: 132-140.
12. Ziakas A, Klinke P, Mildenberger R, Fretz E, Williams M, Della Siega A, Kinloch D, Hilton D,. Comparison of the radial and the femoral approaches in percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 2003; 91: 598-600.
13. Helft G, Dambrin G, Zaman A, et al. Percutaneous coronary intervention in anticoagulated patients via radial artery access. Catheter Cardiovasc Interv 2009; 73: 44-47.
14. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-q-wave myocardial infarction. N Engl J Med 1998; 338: 1488-1497.
15. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS,; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2008 Focused update incorporated into The ACC/AHA 2006 Guidelines For The Management Of Patients With Valvular Heart Disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to develop guidelines for the management of patients with valvular heart disease). J Am Coll Cardiol 2008; 52: e1-e142.
16. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E,. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (3 Suppl): 204S-233S. (Pubitemid 39297955)
17. Doyle BD, Rihal CS, Gastineau DA, Holmes DR,. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention implications for contemporary practice. J Am Coll Cardiol 2009; 53: 2019-2027.
18. MacDonald LA, Meyers S, Bennett CL, Fintel D, Grosshans N, Syegco R, Davidson CJ,. Post-cardiac catheterization access site complications and low-molecular-weight heparin following cardiac catheterization. J Invas Cardiol 2003; 15: 60-62.
19. Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM,. Risk of thromboembolism with short-term interruption of warfarin therapy. Arch Intern Med 2008; 168: 63-69.
20. Agostoni P, Giuseppe GL, Zoccai B, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: Systematic overview and meta analysis of randomised trials. J Am Coll Cardiol 2004; 44: 349-356.
21. Hildick-Smith DJ, Walsh JT, Lowe MD, Petch MC,. Coronary angiography in the fully anticoagulated patient: The transradial route is successful and safe. Catheter Cardiovasc Interv 2003; 58: 8-10.
22. Lo TS, Buch AN, Hall IR, Hildick-Smith DJ, Nolan J,. Percutaneous left and right heart catheterization in fully anticoagulated patients utilizing the radial artery and forearm vein: A two-center experience. J Interv Cardiol 2006; 19: 258-263.
23. Rubboli A, Verheugt FWA,. Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting. A review of the available evidence and practical suggestions for the clinician. Int J Cardiol 2008; 123: 234-239.
24. Ben-Gal Y, Weisz G, Collins MB, Genereux P, Dangas GD, Teirstein PS, Singh VP, Rabbani LE, Kodali SK, Sherman W, Leon MB, Moses JW,. Dual catheter technique for the treatment of severe coronary artery perforations. Catheter Cardiovasc Interv, in press. [Epub ahead of print Jan 4, 2010].
25. Nair P, Roguin A,. Coronary perforations. Eurointervention 2006; 2: 363-370.
26. Berry C, Kelly J, Cobbe SM, Eteiba H,. Comparison of femoral bleeding complications after coronary angiography versus percutaneous coronary intervention. Am J Cardiol 2004; 94: 361-363.
27. Martin JL, Pratsos A, Magargee E, Mayhew K, Pensyl C, Nunn M, Day F, Shapiro T,. A randomized trial comparing compression. Perclose Proglide and Angio-Seal VIP for arterial closure following percutaneous coronary intervention: The CAP trial. Catheter Cardiovasc Interv 2008; 71: 1-5.
28. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G,. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures. A meta-analysis. J Am Coll Cardiol 2004; 44: 1200-1209.
29. Exaire JE, Tcheng JE, Kereiakes DJ, Kleiman NS, Applegate RJ, Moliterno DJ,. Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel. Catheter Cardiovasc Interv 2005; 64: 369-372.
30. ten Berg JM, Hutten BA, Kelder JC, Verheugt FW, Plokker HW,. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications. Circulation 2001; 103: 2042-2047.